BRISTOL-MYERS SQUIBB COMPANY Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $364.00 million as of 2015-12-31, per its 10-K filed 2016-02-12.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2016-02-12
- 2015-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $364.00M.
- 2014-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $446.00M.
- 2013-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $511.00M.
- 2013-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $31.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value as first filed |
|---|---|---|
| 2015-12-31 | $364.00M 10-K · filed 2016-02-12 | |
| 2014-12-31 | $446.00M 10-K · filed 2016-02-12 | |
| 2013-12-31 | $511.00M 10-K · filed 2016-02-12 | |
| 2013-06-30 | $31.00M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $31.00M 10-Q · filed 2013-04-25 | |
| 2012-12-31 | $536.00M 10-K · filed 2015-02-13 | |
| 2012-09-30 | $29.00M 10-Q · filed 2012-10-24 | |
| 2012-06-30 | $29.00M 10-Q · filed 2013-07-25 | |
| 2012-03-31 | $29.00M 10-Q · filed 2013-04-25 | |
| 2011-12-31 | $566.00M 10-K · filed 2014-02-14 | |
| 2011-09-30 | $110.00M 10-Q · filed 2012-10-24 | |
| 2011-06-30 | $110.00M 10-Q · filed 2012-07-25 | |
| 2011-03-31 | $110.00M 10-Q · filed 2012-04-26 | |
| 2010-12-31 | $598.00M 10-K · filed 2013-02-15 | $110.00M 10-K · filed 2011-02-18 |
| 2009-12-31 | $585.00M 10-K · filed 2012-02-17 | $179.00M 10-K · filed 2011-02-18 |
| 2008-12-31 | $297.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |